Use of transfer impedance measurements for clinical assessment of lung mechanics.
Use of transfer impedance measurements for clinical assessment of lung mechanics.
复制标题
使用传输阻抗测量进行肺力学的临床评估。
DOI:
10.1164/ajrccm.157.2.9508067
复制
发表时间:
1998
期刊:
影响因子:
--
通讯作者:
Jackson,AC
中科院分区:
文献类型:
--
作者:
Lutchen,KR;Sullivan,A;Arbogast,FT;Celli,BR;Jackson,AC
Respiratory transfer impedance (Ztr) measured using the forced oscillation technique requires virtually no patient cooperation and provides a noninvasive approach for acquiring data reflective of lung mechanics. Also, model analysis of Ztrprovides reliable estimates of separate airway and tissue properties , but only if data out to 64 Hz are acquired. The current study evaluated the clinical utility of Ztrfrom 1–80 Hz for assessing the degree and type of impaired lung function. Spirometry and Ztrmeasurements were made on 37 individuals: 11 healthy subjects and 26 patients with lung disease including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and sarcoidosis. Over the entire patient group, 12 were also smokers. We first established normal ranges for several Ztrfeatures and model estimated mechanical properties. The COPD and smokers groups showed significant differences in portions of their Ztrspectra from that of the healthy group. Key Ztrspectral features included Ro, the frequency at which the real part of impedance is zero; and Re4, the real part of impedance at 4 Hz. The key model parameter was airway resistance, Raw. We found Raw, Re4, and Roto be significantly elevated during disease (p < 0.0005) and to significantly decrease with bronchodilator therapy (p < 0.025). Moreover, we found moderate to strong correlations between Ro, Raw, and Re4versus FVC and Roversus FEV1. After bronchodilator, changes in Ro, Re4, and Raw were correlated with changes in several spirometric indices. The Rofeature has not been previously evaluated since it is typically above 32 Hz (well above 32 Hz in diseased individuals) and not encompassed in previous clinical studies.
登录
查看更多内容
影响因子:
24.3
作者:
F. Marchal;N. Bouaziz;C. Baeyert;C. Gallina;C. Duvivier;R. Peslin
通讯作者:
R. Peslin
DOI:
--
发表时间:
2015
期刊:
American Review of Respiratory Disease
影响因子:
--
作者:
Kjeldgaard Jm;Richard W. Hyde;Speers Dm;Reichert Ww
通讯作者:
Reichert Ww
影响因子:
3.3
作者:
W. Tomalak;R. Peslin;C. Duvivier;C. Gallina
通讯作者:
C. Gallina
DOI:
--
发表时间:
1989
期刊:
American Review of Respiratory Disease
影响因子:
--
作者:
J. Noord;J. Clement;K. V. D. Woestijne;M. Demedts
通讯作者:
M. Demedts
影响因子:
3.3
作者:
M. Rotger;R. Peslin;E. Oostveen;C. Gallina
通讯作者:
C. Gallina